Loading stock data…
ACHC
$27.85+1.96 (+7.55%)
Market ClosedLast close May 1
Acadia Healthcare Company, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Acadia Healthcare Company, Inc. in the Healthcare sector is trading at $27.85. The stock is currently near its 52-week high of $28.57, remaining 36.9% above its 200-day moving average. Technical signals show neutral RSI of 57 and bearish MACD signal, explaining why ACHC maintains its current momentum and trend strength. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 57) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$27.85
Potential Upside
5%
Whystock Fair Value$29.24
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus14 analysts
Buy
Mean target$24.04-13.7%
Range$13.00 – $31.00
Fundamentals
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilit...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.58B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.71
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
7.14%
Volume
Today's trading volume
5.23M
Recent News
Acadia (ACHC) Q1 2026 Earnings Call Transcript
Debra Osteen: Good morning, and thank you for joining us. On the CTC side of the business, while we grew 2.5% compared to the first quarter of 2025, growth slowed sequentially from quarter 4 as that business was impacted by the severe weather we noted on our February call as certain centers had to be closed during that time.
Acadia Healthcare Q1 Earnings Call Highlights
Acadia Healthcare (NASDAQ:ACHC) reported first-quarter 2026 results that management said came in at the high end of its revenue outlook and above the top end of its Adjusted EBITDA and earnings guidance, driven primarily by growth in its acute inpatient psychiatric business and continued demand acro
Acadia Healthcare Company, Inc. Q1 2026 Earnings Call Summary
Moby summary of Acadia Healthcare Company, Inc.'s Q1 2026 earnings call
Acadia Healthcare (ACHC) Q1 Earnings and Revenues Beat Estimates
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of +31.63% and +0.55%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Acadia Healthcare (NASDAQ:ACHC) Surprises With Q1 CY2026 Sales But Stock Drops
Behavioral health company Acadia Healthcare (NASDAQ:ACHC) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 7.6% year on year to $828.8 million. On the other hand, next quarter’s revenue guidance of $842.5 million was less impressive, coming in 2.7% below analysts’ estimates. Its non-GAAP profit of $0.37 per share was 39.7% above analysts’ consensus estimates.